Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedGastric cancer is now listed as a condition term, and a Genetic and Rare Diseases Information Center resource has been added under Resources.SummaryDifference0.2%

- Check44 days agoChange DetectedDifference0.4%

- Check52 days agoChange DetectedAdded a government funding lapse notice regarding NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedAdded a glossary toggle (Show glossary). Updated metadata labels, including a new revision tag (v3.4.0) and lines such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.2%

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.